Fundraising Fox

Jayson Punwani

Investor

Managing Director at Abingworth

Menlo Park, California

Writes $15M – $30M checks · typically $22.5M

About

Jayson Punwani joined Abingworth's Menlo Park office in November 2021 and serves as Head of Venture, with over 20 years in life sciences venture investing, startup leadership, technology transfer, and academic research. He was previously a Senior Partner at Takeda Ventures focused on early-stage biotech and a Senior Principal at Pappas Ventures, and began his career as a research scientist at Bristol Myers Squibb. He holds an M.B.A. from the University of North Carolina at Chapel Hill, a Ph.D. in biology from the University of Utah, and a B.S. in biology from the College of New Jersey.

LinkedIn ↗X / Twitter ↗

Invests in

Biotech

Experience

  1. AbingworthManaging Directorcurrent2022 — presentMenlo Park, CA
  2. AbingworthPartner2021 — 2022
  3. VertuisInterim CEO2021
  4. Coho TherapeuticsCo-founder2019 — 2021
  5. Takeda Ventures, Inc.Partner2017 — 2020Greater San Diego Area
  6. Pappas CapitalPrincipal2011 — 2017
  7. The Kenan-Flagler Private Equity FundDirector2010 — 2012
  8. University of North Carolina at Chapel HillTechnology Development @ OTD2009 — 2010
  9. University of North Carolina at Chapel HillPostdoctoral Research Associate2008 — 2010

Education

  1. UNC Kenan-Flagler Business SchoolMBA, Finance and Entrepreneurship
  2. University of UtahPhD, Biology
  3. The College of New JerseyBS, Biology

Skills & more

Venture Capital48Valuation15Due Diligence16Alternative Investments3Biotechnology44Biochemistry9Molecular Biology14Start-ups20

From Jayson's professional profile.

Same school

Also attended UNC Kenan-Flagler Business School82

Mathew KayeAccounting Manager at RevolutionFrancesco MoroPrincipal at Burda Principal InvestmentsJoe SantaBarbaraChief Financial Officer at .406 VenturesTony WellsVenture Partner at Copper Sky CapitalTroy ArnoldPartner, Echo Health Advisors at Echo Health VenturesTim SchmidtVice President, Fund Finance at Northpond Ventures

+ 76 more

Also attended University of Utah66

Eric AndersonPartner at Scale Venture PartnersKelly KoVice President of Technology Ventures and Innovation at Flare Capital PartnersTravis HeathAdministrative Partner & CFO at Signal Peak VenturesJason LangInvestor at EPIC VENTURESGeoff SwindleInvestor at EPIC VENTURESTommy AhlquistInvestor at EPIC VENTURES

+ 60 more

Also attended The College of New Jersey12

Megan SteeleController at FinTech CollectiveDonna LittlePartner, Chief Financial Officer, & Chief Compliance Officer at Long Ridge Equity PartnersAury CifuentesPrincipal at How Women InvestElias CanPrincipal at Grishin RoboticsDan MatthiesManaging Partner, Catalyst Fund at ReactionVictor L. ArenaAssociate at Gunderson Dettmer

+ 6 more

Shared employers

Also worked at Abingworth17

Carlos PayaVenture Partner at Ysios CapitalSarah ShackeltonAdvisor at Delin VenturesBali MuralidharGlobal Head of Life Sciences & CIO at AbingworthKurt von EmsterManaging Partner at AbingworthAndrew SinclairManaging Director, Head of Publics & Late Stage at AbingworthTimothy HainesExecutive Partner at Abingworth

+ 11 more

Also worked at Takeda Ventures, Inc.5

Michal SilverbergManaging Director at Novartis Venture FundGraeme MartinVenture Partner at ALSA VenturesIlan ZipkinVenture Partner at Breakout VenturesMiles GersonGeneral Partner at SV Health InvestorsJasmina MarjanovicPartner at Takeda Ventures

Also worked at Pappas Capital2

Dr. Jeff DiLisiExecutive Partner at Tamarind HillScott WeinerPartner at Pappas Capital

Also worked at The Kenan-Flagler Private Equity Fund1

AJ HamelVice President at Plexus Capital

Investments

Led

Coho TherapeuticsStrideBioVelosBioXilio

Board seats

AdditionArmagenDirigentGlycomineMyricxPalleon PharmaceuticalsParcaeSolve Tx

Investor

Aura BiosciencesCoLucidLumena Pharmaceutics

Per the firm's website.

Colleagues at Abingworth

Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth

Network3

Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Genghis Lloyd-Harris
Senior Advisor at Abingworth

Investors connected to Jayson in public investor directories — a warm-intro map.